Last reviewed · How we verify
andrographolide sulfonate simulation
Andrographolide sulfonate is a water-soluble derivative of andrographolide that exerts anti-inflammatory and immunomodulatory effects through multiple cellular pathways.
Andrographolide sulfonate is a water-soluble derivative of andrographolide that exerts anti-inflammatory and immunomodulatory effects through multiple cellular pathways. Used for Upper respiratory tract infection, Acute bronchitis, Inflammation-related conditions.
At a glance
| Generic name | andrographolide sulfonate simulation |
|---|---|
| Also known as | Xiyanping injection simulation |
| Sponsor | Jiangxi Qingfeng Pharmaceutical Co. Ltd. |
| Drug class | Natural product derivative; anti-inflammatory agent |
| Modality | Small molecule |
| Therapeutic area | Immunology; Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
Andrographolide sulfonate is derived from the natural compound andrographolide found in Andrographis paniculata. It functions as a multi-target agent that inhibits NF-κB signaling, reduces pro-inflammatory cytokine production, and modulates immune responses. The sulfonate modification enhances water solubility and bioavailability compared to the parent compound.
Approved indications
- Upper respiratory tract infection
- Acute bronchitis
- Inflammation-related conditions
Common side effects
- Gastrointestinal disturbance
- Allergic reaction
- Rash
Key clinical trials
- Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis (PHASE4)
- Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis (PHASE4)
- A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: